Exelixis Inc (EXEL)
23.71
+0.42
(+1.80%)
USD |
NASDAQ |
Apr 24, 16:00
23.70
0.00 (0.00%)
Pre-Market: 20:00
Exelixis Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.9465 |
| December 31, 2016 | 2.117 |
| September 30, 2016 | 5.960 |
| June 30, 2016 | -2.128 |
| March 31, 2016 | -2.492 |
| December 31, 2015 | -2.968 |
| September 30, 2015 | -5.091 |
| June 30, 2015 | -1.973 |
| March 31, 2015 | -2.510 |
| December 31, 2014 | -3.109 |
| September 30, 2014 | -6.071 |
| June 30, 2014 | 107.61 |
| March 31, 2014 | 4.799 |
| December 31, 2013 | 5.242 |
| September 30, 2013 | 2.573 |
| June 30, 2013 | 1.712 |
| March 31, 2013 | 1.298 |
| December 31, 2012 | 1.133 |
| September 30, 2012 | 0.9837 |
| June 30, 2012 | 1.844 |
| March 31, 2012 | 1.376 |
| December 31, 2011 | 2.003 |
| September 30, 2011 | 68.75 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2019
--
Maximum
Jun 2019
--
Average
--
Median
Jun 2019
Debt to Equity Ratio Benchmarks
| Regeneron Pharmaceuticals Inc | 0.0763 |
| Bristol-Myers Squibb Co | 1.351 |
| Johnson & Johnson | 0.4265 |
| Bio-Techne Corp | 0.2276 |
| Legend Biotech Corp | 0.2248 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 2.942B |
| Total Liabilities (Quarterly) | 678.44M |
| Shareholders Equity (Quarterly) | 2.264B |
| Current Ratio | 3.343 |